Clinical Trials for The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks

Find clinical trials for the incidence of aes and saes receiving verzenios® over a period of approximately 24 weeks. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast

NCT ID: NCT05267327

This clinical trial is studying the safety of a medication called Verzenios® (Abemaciclib) in patients with breast cancer in China. The main goal is to see how often patients experience side effect...

Not yet recruiting

Type: observational

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions